Panel, Conference Presentation
Prevention and Innovation for a Healthier Tomorrow | Global Conference 2024
- Life expectancy is projected to rise in the Western hemisphere and Asia due to declining birth rates and increased longevity, while chronic diseases are predicted to increase driven by lifestyle, nutrition, and varying access to medical services.
- Over 2 million new cancer cases are expected in 2024, with 42% attributed to modifiable risk factors and the potential for a 75% cost difference between stage one and stage four diagnoses; early detection could make patients six to eight times more likely to survive, yet 16% of patients face care disruption due to transportation barriers.
- AI and digital innovation are anticipated to transform clinical workflows by augmenting the workforce, allowing physicians more time with patients, and reducing the 50% of time nurses spend at terminals and 30% looking for supplies through tools like the Oracle Digital Clinical Assistant.
- Financial inefficiencies are highlighted, with 18% of healthcare spend devoted to billing and records creating over $800 billion in annual waste, alongside an expectation of $600 billion in annual GDP loss from preventable predicted events.
- Value-based care is expected to be fully implemented by Medicare by 2030, shifting incentives from treating illness to preventing it, with a $2,000 out-of-pocket cap for drug costs scheduled to begin January 1, 2025.
- Innovation strategies aim to improve equity and access through technologies like the Oracle Digital Clinical Assistant, which integrates social determinants of health, and a cloud-connected platform with 300% more APIs, aiming to utilize a learning health network of over 100 million records.
- Specific disease trajectories include a 5% year-over-year rise in advanced prostate cancer diagnoses due to only 33% of men being screened, alongside expectations that the HPV vaccine will end cervical cancer and prevent 50% of head and neck cancers, with Puerto Rico projected to be the first U.S. location to achieve this.
- Significant inequities persist, with a potential 10-mile gap in care access resulting in a 20-year life expectancy difference, and 42% of those diagnosed with cancer expected to deplete their life savings.
- Funding initiatives such as AHEAD Grants and potential add-on payments for new technologies aim to support wearables, early detection, and cell and gene therapies to reduce financial toxicity and address gaps in neurodegenerative diseases and cancer.
- The U.S. innovation ecosystem is noted as being at risk, yet a 20% reduction in cancer mortality is considered achievable if existing innovations are fully implemented without requiring new developments.